Results

Total Results: 839 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - outcomes of opioid-induced constipation in patients with chronic non-cancer pain in the compose phase … Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release … Measuring withdrawal in a phase 3 study of a new analgesic, nktr-181, in subjects with moderate to … Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients … A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
    October 23, 2014 - For example, liver lesions of less than 1 cm should be evaluated by 3-phase contrast-enhanced CT, MR … , or ultrasound, but liver lesions that are greater than 1 cm in size should be evaluated with 3-phase
  3. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
    January 01, 2020 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists three topics for which preliminary phase III or U.S.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
    January 01, 2010 - important step that is not covered in these training modules occurs during the data extraction and analysis phase … AHRQ Effective Health Care Program Points of Stakeholder Engagement for Systematic Reviews Program Phase
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - our understanding of the literature and discussions with Key Informants during the topic refinement phase … Project staff will meet regularly to discuss the results at each phase, to review studies that are difficult
  6. effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
    January 01, 2010 - important step that is not covered in these training modules occurs during the data extraction and analysis phase … AHRQ Effective Health Care Program Points of Stakeholder Engagement for Systematic Reviews Program Phase
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
    December 06, 2010 - we will retrieve and review the full text of all titles included during the title/abstract review phase
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
    December 06, 2010 - we will retrieve and review the full text of all titles included during the title/abstract review phase
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - preliminary literature reviews in developing the draft protocol during the Comparative Effectiveness Review phase … (118498) 21 Single Blind Method/ (17086) 22 clinical trial/ (476450) 23 clinical trial, phase … i.pt. (12809) 24 clinical trial, phase ii.pt. (20505) 25 clinical trial, phase iii.pt. (7571 … ) 26 clinical trial, phase iv.pt. (759) 27 controlled clinical trial.pt. (85694) 28 randomized
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization … chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal … Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo … A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal … Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
    November 02, 2018 - limit 7 to (adaptive clinical trial or clinical study or clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - 43, figure 5, should make some comment regarding the results for serious adverse events for acute phase
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
    November 01, 2013 - Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence Evidence Report/Technology Assessment Number 213 Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evi…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
    January 01, 2013 - In a topic refinement phase, the scope of the project was refined with input from a panel of Key Informants
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - Source: www.effectivehealthcare.ahrq.gov Published Online: June 04, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations I. Background and Objectives for th…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
    June 16, 2022 - Knowledge and education were excluded as outcomes a priori during the scoping phase of the project … However, search criteria was reviewed with the TEP and with AHRQ during the scoping phase of the project
  20. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - One Phase 1b and two Phase 3 studies1,2,3 are relevant to KQ3 as they contained a TT treatment arm … Additionally, an ongoing Phase 3b single-arm study (NCT02600559)4 that has N>50 subjects, with TT

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: